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SECOND-HAND SMOKE EXPOSURE EFFECTS ON NASAL EPITHELIA PROTEOME  
Background and Objectives 
Environmental secondhand smoke exposure (SHS) results in a statistically significant increase in the risk of diseases such cardiovascular 
diseases and lung cancer. Cigarette smoke contains thousands of constituents, including several carcinogens and cytotoxic chemicals that 
orchestrate chronic inflammatory responses and destructive remodeling events1,2. In this work, our main objective is to uncover biomarkers of 
SHS exposure effects by investigating the proteome of nasal epithelia from health subjects occupationally long–term exposed to SHS. 
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Materials and Methods  Results  
Conclusions 
Prolonged occupational exposure to SHS modulates nasal epithelia proteome associated with pathways and diseases recognized as induced by 
tobacco smoking4. Further validation studies are needed to the better understanding the SHS exposure-induced mechanisms as risk factors for 
airway diseases. 
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Abbreviation: N - Never smokers; F - Former smokers; S - Smokers; NE - Never smokers Exposed to Second Hand Smoking (SHS); 
FE - Former smokers Exposed to SHS; SE - Smokers Exposed to SHS; FVC - forced volume vital capacity (the determination of the 
vital capacity from a maximally forced expiratory effort); FEV1 - volume that has been exhaled at the end of the first second of forced 
expiration, FEV1/FVC is the ration between FEV1 and FVC;  n.a.- not applicable. 
Table 1. Demographics of the study population 
Parameters N F S NE FE SE p-value
Subjects (N) 10 8 8 11 10 4 _
Age (yr) 47.7 ± 15.5 43.0 ± 13.5 45.2 ± 8.6 32.7 ± 7.4 38.8 ± 11.1 35 ± 12.9 p>0.05 (ANOVA)
Gender (F/M) 4/6 3/5 3/5 1/10 2/8 1/3 _
Time in the workplace (years) 7.4 ± 11.5 10.1 ± 7.9 6.4 ± 5.2 9.8 ± 13.3 8.0 ±11.8 5.9 ± 3.5 p>0.05 (ANOVA)
Worktime (hours/week) 43.2 ± 11.3 52.0 ± 4.8 45.2 ± 9.4 37.3 ± 9.1 36.4 ± 8.5 52.5 ± 25
Tobacco smoking  parameters
Tobacco smoking (years) n.a 12.9 ± 10.8 30.3 ± 9.7 n.a 6.5 ± 6.6 17.5 ± 4.8 p>0.05 (T-test) (FvsFE; SvsSE) 
Tobacco smoking(cigarretes/day) n.a 7.8 ± 5.8 15.1 ± 7.7 n.a 13.5 ±17.7 19 ± 8.3 p>0.05 (T-test) (FvsFE; SvsSE) 
Quit of tobacco smoking (years) n.a 13.7 ± 8.1 n.a. n.a 16.3 ± 11.9 n.a. p>0.05 (T-test)
Pulmonary funtion parameters 
FVC 88.1 ± 7.1 96.5 ± 10.7 104.4 ± 20.5 92.8 ± 7.4 96.0 ±14.1 85.8 ± 6.9 p>0.05 (ANOVA)
FEV1 89.6 ± 9.6 96.6 ± 13.6 99.8 ± 18.4 93.4 ± 9.0 95.7 ± 15.9 90.3 ± 10.2 p>0.05 (ANOVA)
FVE1/FVC (BEST) 80.0 ± 3.1 80.7 ± 6.2 76.5 ± 4.6 81.7 ± 5.4 79.9 ± 7.5 85 ± 5 p>0.05 (ANOVA)
Urine cotinine (ng/mL) 5.3 ± 0.46 5.7 ± 1.9 1367.7 ± 692.2 11.0 ± 7.3 5.9 ± 1.0 1873.2 ± 458.7
  p=0.021 (T-test)
Non-Smokers 
(Exposed vs non-Exposed) 
 8.5 vs  5.5  (ng/mL)
p=0.017 (T-test)
 Exposed vs non-Exposed 
  42.1 vs  46.8 (hours/week)
51 WORKERS HAVE BEEN 
INVESTIGATED  
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13 Lisbon restaurants smoking ´mixed’ and 12 smoke free venues 
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SHS-induced PATHWAYS in NASAL EPITHELIA  
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